<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-E9LANWNM</identifier><date>2018</date><creator>Jensterle Sever, Mojca</creator><creator>Kocjan, Tomaž</creator><creator>Preželj, Janez</creator><relation>documents/doc/E/URN_NBN_SI_doc-E9LANWNM_001.pdf</relation><relation>documents/doc/E/URN_NBN_SI_doc-E9LANWNM_001.txt</relation><format format_type="volume">87</format><format format_type="issue">9/10</format><format format_type="type">article</format><format format_type="extent">str. 453-460</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID_HOST">34021081</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-E9LANWNM</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">bisfosfonati</subject><subject language_type_id="eng">bisphosphonates</subject><subject language_type_id="eng">glucocorticoids</subject><subject language_type_id="slv">glukokortikoidi</subject><subject language_type_id="eng">osteoporotic fractures</subject><subject language_type_id="slv">osteoporozni zlomi</subject><title>A position statement of the Slovenian endocrine society on the management of glucocorticoid-induced osteoporosis</title><title>Strokovna stališča Združenja endokrinologov Slovenije o obravnavi glukokortikoidne osteoporoze</title></Record>